A run-in phase clinical study for intravesical administration of durvalumab in patients with high-risk, non-muscle-invasive bladder cancer (NMIBC) by A. Papatsoris, C. Fragkoulis, E. Fragkiadis, A. Pinitas, K. Tzannis, N. Gavalas, K. Stravodimos, K. Ntoumas, D. Mitropoulos, K. Constantinides, E. Giannopoulou, A. Bamias, C. Deliveliotis

Get full text